Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (631-640 of 706) with videos related to

Pageof 71
Sort By:
Clinical Cardiology|September 7, 2020
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
ESC Heart Failure|February 17, 2021
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS ProgramJie Yu, Clare Arnott, Brendon L Neuen, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Circulation|April 6, 2011
Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studiesGiuseppe Patti, Christopher P Cannon, Sabina A Murphy, et al.
Annals of Surgical Oncology|September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomasJennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
American Heart Journal|December 5, 2009
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registryTelly A Meadows, Deepak L Bhatt, Alan T Hirsch, et al.
The New England Journal of Medicine|September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromesLars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Clinical Cardiology|October 15, 2013
Very large database of lipids: rationale and designSeth S Martin, Michael J Blaha, Peter P Toth, et al.
American Heart Journal|January 29, 2026
Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney riskLee-Shing Chang, Shahzad Hassan, Jacqueline Chasse, et al.
Pageof 71

Showing results (631-640 of 706) with videos related to

Sort By:
Pageof 71
Clinical Cardiology|September 7, 2020
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
ESC Heart Failure|February 17, 2021
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS ProgramJie Yu, Clare Arnott, Brendon L Neuen, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Circulation|April 6, 2011
Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studiesGiuseppe Patti, Christopher P Cannon, Sabina A Murphy, et al.
Annals of Surgical Oncology|September 5, 2006
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomasJennifer F Tseng, Matthew T Ballo, Howard N Langstein, et al.
American Heart Journal|December 5, 2009
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registryTelly A Meadows, Deepak L Bhatt, Alan T Hirsch, et al.
The New England Journal of Medicine|September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromesLars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Clinical Cardiology|October 15, 2013
Very large database of lipids: rationale and designSeth S Martin, Michael J Blaha, Peter P Toth, et al.
American Heart Journal|January 29, 2026
Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney riskLee-Shing Chang, Shahzad Hassan, Jacqueline Chasse, et al.
Pageof 71